Xaroban

XAROBAN

Rivaroxaban

SEARLE PAKISTAN (PVT.) LTD.

Drug Identity

Active Ingredient
Rivaroxaban
Drug Class
Antithrombotic Agents
ATC Code
B01AF01
Status
Essential Medicine

How to Take It

Dosage information not available for this product.

Safety Alerts

Creatinine clearance <15 ml/min, active bleeding, in acute coronary syndrome, previous or transient stroke, malignant neoplasms, oesophageal varices, recent brain, ophthalmic, orspinesurgery, GI ulcer, intracranial haemorrhage, significant risk of major bleeding, vascular aneurysm

Important Warnings

Severe renal impairment, Cirrhotic patients with moderate hepatic Impairment, severe hypertension, Spinalor epidural anaesthesia, lumbar puncture

Side Effects

Abdominal painconstipationdiarrhoeadizzinessdyspepsiahaemorrhagehypotensionnauseavomitingpain in extremitiespruritusrenal impairmentangioedemadry mouthmalaise

Drug Interactions

Azole antifungals
protease inhibitors
NSAIDs
strongCYP3A4 inducers
anticoagulants
antiplatelets.

Pregnancy & Lactation

Pregnancy
Contraindicated
Lactation
Not recommended.

Price Intelligence

Rs 321
Servaid observed price · as of 30 July 2026
No approved ceiling matched to this exact pack and strength.
Prices across sources
ServaidRs 321

Should you consider an alternative?

Other options containing Rivaroxaban, and what they are not.You pay Rs 21 more than the cheapest equivalent

For pharma professionalsCompany, market and opportunity intelligence

Company

339
brands
413
molecules
1
alerts

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.